Objective To evaluate the safety and feasibility of radiofrequency ablation (RFA) for hepatic pedicle lesioning in combination with hepatic artery clamping for precise liver resection by establishing a model of precise liver resection in animals. Methods Six healthy Guangxi Bama miniature pigs were selected for this study, and S3, S5 and S6 used as target hepatic segments. The hepatic pedicles were lesioned by radioablation under ultrasound guidance. The hepatic artery was clamped temporarily at the time of radioablation. Three segments (S3, S5 and S6) were resected on each pig. The main outcome measures included the local and general tolerance, the change of blood flow parameters of each segmental arterial and portal branches, and the mi...
Dept. of Medicine/박사[한글] [영문] To overcome the limitation of laparoscopic radiofrequency ab...
To investigate the treatment efficacy of radiofrequency ablation (RFA) of hepatic tumors and the rel...
Radiofrequency ablation (RFA) is a curative treatment option for early stage hepatocellular carcinom...
Background: Radiofrequency ablation (RFA) is a new minimally invasive technique for the treatment of...
The aim of this study was to assess the effect of vascular occlusion on radio-frequency (RF) lesion ...
AbstractBackgroundIntraoperative blood loss during liver resection may be minimized by ablating the ...
AbstractBackground: The liver is the most frequently injured abdominal organ after blunt injury; som...
Surgical advances generally follow either a scientific discovery or a technological breakthrough, fo...
Background: Portal venous blood flow may protect adjacent tumour cells from thermal destruction with...
To quantify the cooling effect of hepatic vessels on liver radiofrequency (RF) ablation ex situ. Bip...
Background. Liver resection is now a standard treatment for primary and secondary hepatic tumors aro...
AbstractBackground. Surgical resection is the most effective therapy for liver cancer. Intraoperativ...
Radiofrequency ablation (RFA) is a method of treating non-resectable liver tumors by use of a high-f...
BACKGROUND: When a major hepatic resection is necessary, sometimes the future liver remnant is not e...
BACKGROUND/AIMS: Experimental radiofrequency ablation has already been performed in healthy livers...
Dept. of Medicine/박사[한글] [영문] To overcome the limitation of laparoscopic radiofrequency ab...
To investigate the treatment efficacy of radiofrequency ablation (RFA) of hepatic tumors and the rel...
Radiofrequency ablation (RFA) is a curative treatment option for early stage hepatocellular carcinom...
Background: Radiofrequency ablation (RFA) is a new minimally invasive technique for the treatment of...
The aim of this study was to assess the effect of vascular occlusion on radio-frequency (RF) lesion ...
AbstractBackgroundIntraoperative blood loss during liver resection may be minimized by ablating the ...
AbstractBackground: The liver is the most frequently injured abdominal organ after blunt injury; som...
Surgical advances generally follow either a scientific discovery or a technological breakthrough, fo...
Background: Portal venous blood flow may protect adjacent tumour cells from thermal destruction with...
To quantify the cooling effect of hepatic vessels on liver radiofrequency (RF) ablation ex situ. Bip...
Background. Liver resection is now a standard treatment for primary and secondary hepatic tumors aro...
AbstractBackground. Surgical resection is the most effective therapy for liver cancer. Intraoperativ...
Radiofrequency ablation (RFA) is a method of treating non-resectable liver tumors by use of a high-f...
BACKGROUND: When a major hepatic resection is necessary, sometimes the future liver remnant is not e...
BACKGROUND/AIMS: Experimental radiofrequency ablation has already been performed in healthy livers...
Dept. of Medicine/박사[한글] [영문] To overcome the limitation of laparoscopic radiofrequency ab...
To investigate the treatment efficacy of radiofrequency ablation (RFA) of hepatic tumors and the rel...
Radiofrequency ablation (RFA) is a curative treatment option for early stage hepatocellular carcinom...